Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women

Gynecological Endocrinology

Volumn 24, Issue 3, 2008, Pages 117-121

  Serin, Ibrahim Serdar ^a   Tanriverdi, Fatih ^a   Yilmaz, Mustafa Oguz ^a   Ozcelik, Bulent ^a   Unluhizarci, Kursad ^a  

^a ERCIYES UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Insulin like growth factor binding protein 3; Insulin like growth factor I; Leptin; Ovarian tumor

Indexed keywords

CA 125 ANTIGEN; GLUCOSE; LEPTIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ARTICLE; BENIGN TUMOR; CANCER PATIENT; CANCER TISSUE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HISTOPATHOLOGY; HOMEOSTASIS MODEL ASSESSMENT; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; OVARY CARCINOMA; POSTMENOPAUSE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TUMOR DIFFERENTIATION;

CA-125 ANTIGEN; FEMALE; HOMEOSTASIS; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; POSTMENOPAUSE; TUMOR MARKERS, BIOLOGICAL;

EID: 40549083691     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.1080/09513590801895559     Document Type: Article

References (30)

1. Auersperg N, Wong AS, Choi KC, Kang SK, Leung PC. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001;22:255-258.
2. Pollak MN, Schernhammer ES, Hankinson SE. Insulin-like growth factors and neoplasia. Nat Rev Cancer 2004;4:505-518.
3. Fürstenberger G, Senn HJ. Insulin-like growth factors and cancer. Lancet Oncol 2002;3:298-302.
4. LeRoith D, Roberts CT. The insulin-like growth factor system and cancer. Cancer Lett 2003;195:127-137.
5. Karasik A, Menczer J, Pariente C, Kanety H. Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer. J Clin Endocrinol Metab 1994;78:271-276.
6. Katsaros D, Yu H, Levesque MA, Danese S, Genta F, Richiardi G, Fracchioli S, Khosravi MJ, Diamandi A, Gordini G, et al. IGFBP-3 in epithelial ovarian carcinoma and its association with clinico-pathological features and patient survival. Eur J Cancer 2001;37:478-485.
7. Lukanova A, Lundin E, Toniolo P, Micheli A, Akhmedkhanov A, Rinaldi S, Muti P, Lenner P, Biessy C, Krogh V, et al. Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2002;101:549-554.
8. Stoll BA. Western nutrition and the insulin resistance syndrome: a link to breast cancer. Eur J Clin Nutr 1999;53:83-87.
9. Carroll KK. Obesity as a risk factor for certain types of cancer. Lipids 1998;33:1055-1059.
10. Frost C, Coleman MP. Obesity and ovarian cancer. Eur J Cancer 1997;33:1529-1531.
11. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subject with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
12. Stepherd JH. Revised FIGO staging for gynecological cancer. Br J Obstet Gynecol 1989;96:889-892.
13. Maculay VM. Insulin like growth factors and cancer. Br J Cancer 1992;65:311-320.
14. Holly JM, Gunnell DJ, Smith DG. Growth hormone, IGF-1 and cancer. Less intervention to avoid cancer? More intervention to prevent cancer? J Endocrinol 1999;162:21-30.
15. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. J Endocr Rev 1995;16:3-34.
16. Sierra-Honigmann MR, Nath AK, Murakami C, Garcia-Cardena G, Papapetropoulos A, Sessa WC, Madge LA, Schechner JS, Schwabb MB, Polverini PJ, et al. Biological action of leptin as an angiogenic factor. Science 1998;281:1683-1686.
17. Sohda M, Kato H, Miyazaki T, Nakajima M, Fukuchi M, Manda R, Fukai Y, Masuda N, Kuwano H. The role of insulin-like growth factor I and insulin like growth factor binding protein 3 in human esophageal cancer. Anticancer Res 2004;24:3029-3034.
18. Gregoire Nyomba BL, Johnson M, Berard L, Murphy LJ. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 1999;48:840-844.
19. Shah NG, Bhatavdekar JM, Doctor SS, Suthar TP, Balar DB, Dave RS. Circulating epidermal growth factor (IGF-I) in patients with epithelial ovarian carcinoma. Neoplasma 1994;41:241-243.
20. Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R, Soler J. Interactions between serum leptin, the insulin-like growth factor-I system, and sex, age, anthropometric and body composition variables in a healthy population randomly selected. Clin Endocrinol (Oxf) 2003;58:213-219.
21. Park HY, Kwon HM, Lim HJ. Potetial role of leptin in angiogenesis: leptin induces endothelial cell proliferation and expression of matrix metalloproteinases in vivo and in vitro. Exp Mol Med 2001;33:95-102.
22. Laud K, Gourdou I, Pessemesse L. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line. Mol Cell Endocrinol 2002;188:219-226.
23. Bouloumie A, Drexler HC, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998;83:1059-1066.
24. Stattin P, Palmqvist R, Soderberg S, Biessy C, Ardnor B, Hallmans G, Kaaks R, Olsson T. Plasma leptin and colorectal cancer risk: a prospective study in Northern Sweden. Oncol Rep 2003;10:2015-2021.
25. Stattin P, Soderberg S, Biessy C, Lenner P, Hallmans G, Kaaks R, Olsson T. Plasma leptin and breast cancer risk: a prospective study in northern Sweden. Breast Cancer Res Treat 2004;86:191-196.
26. Dulger H, Alici S, Sekeroglu MR, Erkog R, Ozbek H, Noyan T, Yavuz M. Serum levels of leptin and proinflammatory cytokines in patients with gastrointestinal cancer. Int J Clin Pract 2004;58:545-549.
27. Lagiou P, Signorello LB, Trichopoulos D, Tzonou A, Trichopoulou A, Mantzoros CS. Leptin in relation to prostate cancer and benign prostatic hyperplasia. Int J Cancer 1998;76:25-28.
28. Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E, Trichopoulos D. Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 2002;46:147-151.
29. Cymbaluk A, Chudecka-Glaz A, Rzepka-Gorska I. Leptin levels in serum depending on body mass index in patients with endometrial hyperplasia and cancer. Eur J Obstet Gynecol Reprod Biol 2008;136:74-77.
30. Lebrecht A, Ludwig E, Huber A, Klein M, Schneeberger C, Tempfer C, Koelbl H, Hefler L. Serum vascular endothelial growth factor and serum leptin in patients with cervical cancer. Gynecol Oncol 2002;85:32-35.